Ryman Healthcare (Germany) Buy Hold or Sell Recommendation
| RH7 Stock | EUR 2.49 0.01 0.40% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Ryman Healthcare Limited is 'Strong Hold'. Macroaxis provides Ryman Healthcare buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RH7 positions.
Check out Ryman Healthcare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ryman and provide practical buy, sell, or hold advice based on investors' constraints. Ryman Healthcare Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Ryman |
Execute Ryman Healthcare Buy or Sell Advice
The Ryman recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ryman Healthcare Limited. Macroaxis does not own or have any residual interests in Ryman Healthcare Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ryman Healthcare's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ryman Healthcare Trading Alerts and Improvement Suggestions
| Ryman Healthcare generated a negative expected return over the last 90 days | |
| Ryman Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| The company has €2.58 Billion in debt which may indicate that it relies heavily on debt financing | |
| Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 61.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Ryman Healthcare has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity. |
Ryman Healthcare Returns Distribution Density
The distribution of Ryman Healthcare's historical returns is an attempt to chart the uncertainty of Ryman Healthcare's future price movements. The chart of the probability distribution of Ryman Healthcare daily returns describes the distribution of returns around its average expected value. We use Ryman Healthcare Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ryman Healthcare returns is essential to provide solid investment advice for Ryman Healthcare.
| Mean Return | 0.05 | Value At Risk | -3.24 | Potential Upside | 3.72 | Standard Deviation | 2.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ryman Healthcare historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ryman Healthcare Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ryman Healthcare or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ryman Healthcare's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ryman stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 2.18 | |
Ir | Information ratio | 0.01 |
Ryman Healthcare Volatility Alert
Ryman Healthcare Limited currently demonstrates below-average downside deviation. It has Information Ratio of 0.01 and Jensen Alpha of 0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ryman Healthcare's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ryman Healthcare's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ryman Healthcare Fundamentals Vs Peers
Comparing Ryman Healthcare's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ryman Healthcare's direct or indirect competition across all of the common fundamentals between Ryman Healthcare and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ryman Healthcare or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ryman Healthcare's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ryman Healthcare to competition |
| Fundamentals | Ryman Healthcare | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | -7.0E-4 | -0.14 |
| Profit Margin | 1.13 % | (1.27) % |
| Operating Margin | (0.02) % | (5.51) % |
| Current Valuation | 3.82 B | 16.62 B |
| Shares Outstanding | 530.46 M | 571.82 M |
| Shares Owned By Insiders | 11.54 % | 10.09 % |
| Shares Owned By Institutions | 16.69 % | 39.21 % |
| Price To Earning | 15.33 X | 28.72 X |
| Price To Book | 0.93 X | 9.51 X |
| Price To Sales | 3.46 X | 11.42 X |
| Revenue | 503.76 M | 9.43 B |
| Gross Profit | 42.52 M | 27.38 B |
| EBITDA | 788.44 M | 3.9 B |
| Net Income | 692.87 M | 570.98 M |
| Total Debt | 2.58 B | 5.32 B |
| Debt To Equity | 61.60 % | 48.70 % |
| Current Ratio | 0.64 X | 2.16 X |
| Book Value Per Share | 7.26 X | 1.93 K |
| Cash Flow From Operations | 585.98 M | 971.22 M |
| Earnings Per Share | 0.66 X | 3.12 X |
| Price To Earnings To Growth | 2.57 X | 4.89 X |
| Number Of Employees | 6.8 K | 18.84 K |
| Beta | 0.79 | -0.15 |
| Market Capitalization | 1.99 B | 19.03 B |
| Total Asset | 10.97 B | 29.47 B |
| Annual Yield | 0.04 % | |
| Net Asset | 10.97 B | |
| Last Dividend Paid | 0.22 |
Ryman Healthcare Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ryman . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 10.84 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.5 | |||
| Day Typical Price | 2.49 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Ryman Healthcare Buy or Sell Advice
When is the right time to buy or sell Ryman Healthcare Limited? Buying financial instruments such as Ryman Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ryman Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities Thematic Idea Now
Utilities
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ryman Stock
Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.